Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis

AIMS: Hereditary transthyretin (ATTRv) amyloidosis is the most frequent and representative form of autosomal dominant hereditary systemic amyloidosis. Disease‐modifying treatments of the disease are more effective during the early stages, and we require biomarkers to detect early pathological change...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ESC Heart Fail
Auteurs principaux: Okada, Masamitsu, Misumi, Yohei, Masuda, Teruaki, Takashio, Seiji, Tasaki, Masayoshi, Matsushita, Hiroaki, Ueda, Akihiko, Inoue, Yasuteru, Nomura, Toshiya, Nakajima, Makoto, Yamashita, Taro, Shinriki, Satoru, Matsui, Hirotaka, Tsujita, Kenichi, Ando, Yukio, Ueda, Mitsuharu
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Original Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006664/
https://ncbi.nlm.nih.gov/pubmed/33381924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13176
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires